These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21061679)

  • 1. [Detection of DNA hypermethylation as a potential biomarker for prostate cancer].
    Tilandyová P; Kajo K; Kliment J; Plank L; Lasabová Z
    Klin Onkol; 2010; 23(5):293-9. PubMed ID: 21061679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GSTP1 CpG island hypermethylation as a molecular biomarker for prostate cancer.
    Nakayama M; Gonzalgo ML; Yegnasubramanian S; Lin X; De Marzo AM; Nelson WG
    J Cell Biochem; 2004 Feb; 91(3):540-52. PubMed ID: 14755684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylated genes as potential biomarkers in prostate cancer.
    Phé V; Cussenot O; Rouprêt M
    BJU Int; 2010 May; 105(10):1364-70. PubMed ID: 20067451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci.
    Bastian PJ; Ellinger J; Wellmann A; Wernert N; Heukamp LC; Müller SC; von Ruecker A
    Clin Cancer Res; 2005 Jun; 11(11):4097-106. PubMed ID: 15930345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy.
    Bastian PJ; Palapattu GS; Lin X; Yegnasubramanian S; Mangold LA; Trock B; Eisenberger MA; Partin AW; Nelson WG
    Clin Cancer Res; 2005 Jun; 11(11):4037-43. PubMed ID: 15930338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypermethylation of the CpG islands in the promoter region flanking GSTP1 gene is a potential plasma DNA biomarker for detecting prostate carcinoma.
    Chuang CK; Chu DC; Tzou RD; Liou SI; Chia JH; Sun CF
    Cancer Detect Prev; 2007; 31(1):59-63. PubMed ID: 17291695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia.
    Kang GH; Lee S; Lee HJ; Hwang KS
    J Pathol; 2004 Feb; 202(2):233-40. PubMed ID: 14743506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular detection of prostate cancer: a role for GSTP1 hypermethylation.
    Henrique R; Jerónimo C
    Eur Urol; 2004 Nov; 46(5):660-9; discussion 669. PubMed ID: 15474280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypermethylation of the CpG islands in the promoter region of the GSTP1 gene in prostate cancer: a useful diagnostic and prognostic marker?
    Bernardini S; Miano R; Iori R; Finazzi-Agrò E; Palmieri G; Ballerini S; Angeloni C; Orlandi A; Bellincampi L; Cortese C; Federici G
    Clin Chim Acta; 2004 Dec; 350(1-2):181-8. PubMed ID: 15530476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The emerging roles of DNA methylation in the clinical management of prostate cancer.
    Perry AS; Foley R; Woodson K; Lawler M
    Endocr Relat Cancer; 2006 Jun; 13(2):357-77. PubMed ID: 16728568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer.
    Ellinger J; Haan K; Heukamp LC; Kahl P; Büttner R; Müller SC; von Ruecker A; Bastian PJ
    Prostate; 2008 Jan; 68(1):42-9. PubMed ID: 18004747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter hypermethylation of GSTP1, AR, and 14-3-3sigma in serum of prostate cancer patients and its clinical relevance.
    Reibenwein J; Pils D; Horak P; Tomicek B; Goldner G; Worel N; Elandt K; Krainer M
    Prostate; 2007 Mar; 67(4):427-32. PubMed ID: 17192910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular detection of localized prostate cancer using quantitative methylation-specific PCR on urinary cells obtained following prostate massage.
    Rouprêt M; Hupertan V; Yates DR; Catto JW; Rehman I; Meuth M; Ricci S; Lacave R; Cancel-Tassin G; de la Taille A; Rozet F; Cathelineau X; Vallancien G; Hamdy FC; Cussenot O
    Clin Cancer Res; 2007 Mar; 13(6):1720-5. PubMed ID: 17363525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects.
    Hoque MO; Topaloglu O; Begum S; Henrique R; Rosenbaum E; Van Criekinge W; Westra WH; Sidransky D
    J Clin Oncol; 2005 Sep; 23(27):6569-75. PubMed ID: 16170165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The usefulness of the detection of GSTP1 methylation in urine as a biomarker in the diagnosis of prostate cancer.
    Woodson K; O'Reilly KJ; Hanson JC; Nelson D; Walk EL; Tangrea JA
    J Urol; 2008 Feb; 179(2):508-11; discussion 511-2. PubMed ID: 18076912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of GSTP1 CpG island hypermethylation and reactivation of pi-class glutathione S-transferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide.
    Lin X; Asgari K; Putzi MJ; Gage WR; Yu X; Cornblatt BS; Kumar A; Piantadosi S; DeWeese TL; De Marzo AM; Nelson WG
    Cancer Res; 2001 Dec; 61(24):8611-6. PubMed ID: 11751372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High promoter methylation levels of APC predict poor prognosis in sextant biopsies from prostate cancer patients.
    Henrique R; Ribeiro FR; Fonseca D; Hoque MO; Carvalho AL; Costa VL; Pinto M; Oliveira J; Teixeira MR; Sidransky D; Jerónimo C
    Clin Cancer Res; 2007 Oct; 13(20):6122-9. PubMed ID: 17947477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CpG island hypermethylation at multiple gene sites in diagnosis and prognosis of prostate cancer.
    Ellinger J; Bastian PJ; Jurgan T; Biermann K; Kahl P; Heukamp LC; Wernert N; Müller SC; von Ruecker A
    Urology; 2008 Jan; 71(1):161-7. PubMed ID: 18242387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutathione S-transferase pi (GSTP1) hypermethylation in prostate cancer: review 2007.
    Meiers I; Shanks JH; Bostwick DG
    Pathology; 2007 Jun; 39(3):299-304. PubMed ID: 17558856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features.
    Cho NY; Kim BH; Choi M; Yoo EJ; Moon KC; Cho YM; Kim D; Kang GH
    J Pathol; 2007 Feb; 211(3):269-77. PubMed ID: 17139617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.